Broke above 217.88 (yellow line) heavy resistance premarket.
Good news has been coming out of this company as far as vaccine trials.
American FDA approval could come around may and with that AstraZeneca nightmare in Germany, early Europe approval could be in play.
stop loss at 217
Targets are Fibonacci (Greenlines)
Good news has been coming out of this company as far as vaccine trials.
American FDA approval could come around may and with that AstraZeneca nightmare in Germany, early Europe approval could be in play.
stop loss at 217
Targets are Fibonacci (Greenlines)